Company Filing History:
Years Active: 2022
Title: The Innovations of Hai Chen
Introduction
Hai Chen is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of gene combinations that enhance the expression of recombinant human nerve growth factor (rhNGF). His work has the potential to impact therapeutic approaches for nerve-related conditions.
Latest Patents
Hai Chen holds a patent for a gene combination capable of high-efficiency expression of recombinant human nerve growth factor. This innovative gene combination optimizes gene expression regulation components, leading to enhanced expression of rhNGF. Experimental results demonstrate that this gene combination achieves high-efficiency expression of rhNGF with natural activity in a eukaryotic expression system. He has 1 patent to his name.
Career Highlights
Currently, Hai Chen is associated with Xintrum Pharmaceuticals, Ltd., where he continues to advance his research in biotechnology. His work focuses on optimizing gene expression for therapeutic applications, showcasing his commitment to innovation in the field.
Collaborations
Hai Chen collaborates with notable colleagues, including Hongliang Sun and Yi Zhang. Their combined expertise contributes to the advancement of their research projects and the development of new biotechnological solutions.
Conclusion
Hai Chen's contributions to the field of biotechnology, particularly through his patent on gene combinations for rhNGF expression, highlight his role as an innovative inventor. His work at Xintrum Pharmaceuticals, along with his collaborations, positions him as a key figure in advancing therapeutic applications in biotechnology.